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Article
IL-2/IL-7-inducible factors pioneer the path
to T cell differentiation in advance of
lineage-defining factors
Sarah L Bevington1,* , Peter Keane1 , Jake K Soley1, Saskia Tauch1, Dominika W Gajdasik2,
Remi Fiancette2, Veronika Matei-Rascu2, Claire M Willis2, David R Withers2,** &
Peter N Cockerill1,***
Abstract
When dormant naïve T cells first become activated by antigen-
presenting cells, they express the autocrine growth factor IL-2
which transforms them into rapidly dividing effector T cells. During
this process, hundreds of genes undergo epigenetic reprogram-
ming for efficient activation, and also for potential reactivation
after they return to quiescence as memory T cells. However, the
relative contributions of IL-2 and T cell receptor signaling to this
process are unknown. Here, we show that IL-2 signaling is required
to maintain open chromatin at hundreds of gene regulatory
elements, many of which control subsequent stimulus-dependent
alternative pathways of T cell differentiation. We demonstrate that
IL-2 activates binding of AP-1 and STAT5 at sites that can subse-
quently bind lineage-determining transcription factors, depending
upon what other external factors exist in the local T cell environ-
ment. Once established, priming can also be maintained by the
stroma-derived homeostatic cytokine IL-7, and priming diminishes
if Il7r is subsequently deleted in vivo. Hence, IL-2 is not just a
growth factor; it lays the foundation for T cell differentiation and
immunological memory.
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Introduction
The adaptive immune system in mammals relies on T lymphocytes
which express a wide range of immune modulators and defense
molecules when they respond to a specific foreign antigen (Ag).
Although T cells exit the thymus as mature T cells, they remain
fixed in a relatively unresponsive state as naı̈ve T cells until they
undergo further differentiation triggered by encounters with antigen
(Ag). CD4 helper T cells only acquire their true potential within the
immune system after their commitment to differentiate to different
types of effector T cells equipped to respond to different classes of
pathogens presenting in different environments.
When naı̈ve T cells are activated by Ag-presenting cells for the
first time via T cell receptor (TCR) and CD28 co-receptor signaling,
they rapidly turn on expression of the autocrine growth factor inter-
leukin-2 (IL-2) and its receptor IL-2Ra, and undergo extensive
genome-wide chromatin reorganization during their transformation
into rapidly dividing T-blast cells. This process is driven by the
TCR/CD28-inducible transcription factors (TFs) NFAT, AP-1, NF-jB,
and EGR1 (Yukawa et al, 2019), and supported by the IL-2-inducible
TFs AP-1 and STAT5 (Liao et al, 2011a; Ross & Cantrell, 2018). Acti-
vation of STAT5 is mediated by phosphorylation via JAK1/3 which
gets recruited to the IL-2 receptor in response to binding of IL-2
(Miyazaki et al, 1994), whereas AP-1 induction involves transcrip-
tional activation via RAS and kinase signaling, which is also acti-
vated by TCR signaling. These TFs, in turn, activate hundreds of
inducible immune response genes and create thousands of open
chromatin regions identified as DNase I hypersensitive sites (DHSs)
which represent enhancer and promoter elements that activate the
expression of inducible immune response genes. Once TCR signal-
ing ceases and inducible TFs are down-regulated, the majority of
these sites disappear. However, ~ 3,000 regions are stably main-
tained as epigenetically primed DHSs (pDHSs) which function to
preserve transcriptional and immunological memory once a T cell
loses contact with an Ag-presenting cell (Bevington et al, 2016).
These pDHSs establish islands of active chromatin encompassing
the inducible promoters and enhancers, thereby enabling the TCR-
inducible genes to be rapidly reactivated more efficiently when
effector T cells and memory T cells re-encounter Ag (Fig 1A;
Bevington et al, 2016, 2017a,b). Furthermore, the majority of these
pDHSs do not function as classical enhancers because their presence
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has no impact on steady-state levels of transcription, or on the activ-
ity of reporter genes in transfection assays (Bevington et al, 2016,
2017a). Hence, pDHSs make it possible to maintain inducible genes
in a poised non-transcribed state while also enabling rapid reactiva-
tion. pDHSs are stably maintained in both rapidly dividing T-blast
cells in vitro and in quiescent memory T cells in vivo by binding
constitutively expressed TFs such as RUNX1 and ETS1. However,
many pDHSs also have binding sites for IL-2-inducible STAT5 and
AP-1 proteins, suggesting a potential additional role for IL-2 in the
formation and/or maintenance of these sites. Importantly, while the
initial activation and any subsequent reactivation of immune
response genes in T cells is highly dependent on TCR signaling, the
maintenance of the proliferative response and transcriptional
memory can be supported by just IL-2 in the absence of Ag (Beving-
ton et al, 2016).
IL-2 binds to its receptor via the IL-2-specific chain IL-2Ra but
signals via the common gamma chain (cc) which is shared by the
receptors for five other cytokines (IL-4, IL-7, IL-9, IL-15, and IL-21)
(Liao et al, 2011a; Ross & Cantrell, 2018; Leonard et al, 2019) which
are important for the action and response of many cells in the
immune system (Read et al, 2016; Ross & Cantrell, 2018). IL-2, IL-7,
and IL-15 are collectively integral to the establishment, homeostasis,
and maintenance of memory T cells (Raeber et al, 2018). Although
the role of IL-2 as a T cell growth factor for recently activated T cells
has been known for many decades (Morgan et al, 1976), it also
plays an important role during memory T cell formation since loss
of IL-2 signaling early during T cell activation impairs subsequent
memory T cell recall (Williams et al, 2006; Pepper et al, 2011).
Furthermore, IL-2 is also needed early during T cell activation for
the later expression of IL-7Ra, which is required for the formation of
the memory T cell pool (Dooms et al, 2007).
Following their initial activation, CD4 T cells are normally
destined to differentiate to become specialized effector helper T (Th)
cells, such as Th1, Th2, or Th17, which each express a different
specific subset of immune response genes (Zhu et al, 2010). This
process is driven by different cytokines which are expressed by vari-
ous cell types in response to different pathogens (Fig 1B). Cytokine
activity triggers signaling via different classes of STAT proteins and
activates expression of alternative lineage-determining TFs, depend-
ing upon the circumstances: Viral and bacterial infections typically
result in local expression of IL-12, which triggers signaling via
STAT4 and expression of the TF T-BET (Tbx21) which drives Th1
differentiation and expression of IFNc (Szabo et al, 2003); parasitic
infections typically result in local expression of IL-4, which triggers
signaling via STAT6 and expression of the TF GATA3 which drives
Th2 differentiation and expression of IL-4 and IL-5 (Ansel et al,
2006); mucosal membrane infections typically result in local expres-
sion of IL-6, which triggers signaling via STAT3 and expression of
the TF RORct (Rorc) which drives Th17 differentiation and expres-
sion of IL-17 (Littman & Rudensky, 2010). It has previously been
widely presumed that factors such as T-BET, GATA3, and RORct
function as true pioneer factors, much like the archetypal pioneer
factor FOXA1 (Cirillo et al, 2002), and are able to initiate the
process of opening up previously inaccessible chromatin domains,
thereby triggering lineage-specific gene expression.
While it is accepted that epigenetic modifications and TF action
play crucial roles in T cell activation, differentiation, and memory
(Abdelsamed et al, 2018), little is known regarding the extent to
which cc cytokines contribute to the establishment or maintenance
of epigenetic modifications acquired by previously activated T cells,
and for the priming the cytokine-dependent induction of terminal
T cell differentiation. STAT5, AP-1, and IL-2 have been implicated in
the regulation of T cell activation and polarization in Th1 (Shi et al,
2008; Liao et al, 2011b; Zeng et al, 2016), and Th2 cells (Ben-Sasson
et al, 1990; Le Gros et al, 1990; Rincon & Flavell, 1997; Hartenstein
et al, 2002; Zhu et al, 2003; Cote-Sierra et al, 2004; Yamane et al,
2005; Betz et al, 2010; Ross & Cantrell, 2018) with enrichment of
AP-1 and STAT motifs at distal elements that were also enriched
with motifs for lineage-specific transcription factors (Zeng et al,
2016). Finally, IL-2 contributes directly to Th1 differentiation by
promoting expression of IL-12Rb1 and IL-12Rb2, and to Th2 dif-
ferentiation by promoting expression of IL4-Ra and by priming the
locus control region (LCR) of the locus encompassing genes encod-
ing the Th2 cytokines IL-4, IL-13, and IL-5 (Liao et al, 2008, 2011b).
To determine the role of IL-2 in this process, we examined the
in vitro responses of recently activated T cells to short-term with-
drawal of IL-2. We show that IL-2 is required to maintain 1,000
pDHSs bound by STAT5 and AP-1 in recently activated and rapidly
proliferating CD4 T-blast cells and that most of these sites also
represent DHSs that respond subsequently to lineage-defining
cytokines and TFs. Thus, IL-2 signaling does not just act early to
support transformation of quiescent naı̈ve T cells but plays a
genome-wide role in establishing lineage-specific patterns of gene
regulation long before the first appearance of lineage-specific
factors.
Results
IL-2 is required to maintain a subset of DHSs in recently
activated T-blast cells
To identify specific roles for IL-2 signaling in T cell development,
we investigated its contribution to maintaining pDHSs in recently
activated proliferating CD4 T-blast cells (TB). We performed multi-
ple genome-wide analyses of actively dividing T-blast cells immedi-
ately after a cycle of transient TCR activation, followed by culture
with IL-2, but before the cells are polarized toward different T
helper cell subsets in the presence of lineage-defining cytokines and
TFs. Hence, we are studying very early reprogramming events that
take place in Th0 cells prior to terminal differentiation which can
take several additional days or weeks (Agarwal & Rao, 1998).
To investigate the role that this pan T cell-specific cytokine plays
in maintaining priming in Th0 cells, we employed an ex vivo T-blast
transformation model system (Fig 1C). In this model, TCR signaling
is activated in CD4 naı̈ve T cells (TN) using concanavalin A (ConA)
for 40 h, and following transformation, rapidly proliferating T-blast
cells are maintained in culture and undergo several cell divisions in
the presence of IL-2 in place of ConA. In the presence of just IL-2,
the transcriptional profile of TCR-inducible genes in TB cells returns
to steady-state levels more similar to that seen in TN cells prior to
transformation. However, many of the recently activated immune
response genes still maintain epigenetic priming in the absence of
TCR/CD28 signaling, thereby enabling much faster reactivation by
TCR signaling than occurs in TN cells (Bevington et al, 2016). To
assess the role of IL-2 in the maintenance of this epigenetic priming,
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recently transformed TB cells were first cultured with IL-2 for 30 h
and then for 16 h in the absence of IL-2. Removal of lL-2 from the
cultures led to a significant reduction in Il2ra mRNA expression,
suggesting that the contribution from any autologous IL-2 will be
limited (Fig EV1A).
To measure levels of epigenetic priming, we performed DNase-
Seq to identify all open chromatin regions containing active regula-
tory elements. CD4 TB cells were cultured in the presence or
absence of IL-2 (TB IL-2 and TB IL-2nil), non-apoptotic live cells
were purified (Fig EV1B) before DNase I treatment, and the DHSs
were ranked according to the fold change in the DNA sequence tag
count of peaks in TB IL-2 compared to TB IL-2nil (Figs 2A and
EV1C). In the absence of IL-2, 1,000 IL-2-dependent DHSs (IL-2
pDHSs) were reduced in size by at least twofold in each of 2 repli-
cates (Figs 2B and EV1C, Table EV1). Many of these IL-2-dependent
sites (286) were included within the group of 2,882 primed DHSs
that we previously showed were maintained in vivo in memory
phenotype T cells (Bevington et al, 2016; Fig EV1D). Indeed, in the
absence of IL-2 there was a substantial reduction in average DNase I
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Figure 1. CD4 T cell activation and differentiation.
A Model of an epigenetically primed inducible locus before and after reactivation of TCR/CD28 signaling.
B Schematic of alternative pathways of cytokine-induced helper T cell differentiation in giving rise to Th1, Th2, or Th17 subtypes of helper T cells.
C Schematic of T-blast cell transformation. Purified CD4 T cells were activated with ConA for 40 h and maintained in IL-2 or IL-7 for 30 h as TB. Cells were cultured
for a further 16 h  IL-2, IL-7, or Ruxolitinib. Cells were re-stimulated (TB+) with 20 ng/ml PMA and 2 mM calcium Ionophore (PMA/I) for 2 h.
D, E Schematics of the procedures for generating Th1 cells in response to intravenous infection of bacteria (D) and Th17 cells by oral infection with bacteria (E).
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compared to a control group of 2,882 invariant DHSs shared by TB
and TN (Fig EV1E).
To investigate whether the IL-2 pDHSs defined in vitro were also
stably propagated in previously activated T cells in vivo, we looked to
see whether they were present in purified in vivo-differentiated T cells.
For this purpose, we generated (i) Ag-specific Th1 memory T cells by
immunizing mice with attenuated Listeria monocytogenes expressing
the 2W1S peptide (Lm-2W1S), and purifying the 2W1S-specific T cells
56 days later (Fig 1D; Pepper et al, 2010), and (ii) bonafide Th17 cells
by orally infecting Il17acre × ROSA26tdRFP+ mice with Citrobacter
rodentium and sort purifying colonic tdRFP+ fate-mapped CD4 T cells
7 days later (Fig 1E; Hirota et al, 2011). We also made use of
published data sets from Th2 cells (Shih et al, 2016), regulatory T cells
(Treg) (Garg et al, 2019), and T follicular helper cells (Tfh) (Chen
et al, 2020). Significantly, we were able to detect open chromatin
regions corresponding to 26–52% of the 1,000 IL-2 pDHSs in each of
these five subsets of differentiated CD4 T cells (Fig 2A and C). Further-
more, 65% of the 1,000 IL-2 pDHSs were present in at least one of the
Th1, Th2, or Th17 subsets (Fig 2D), indicating that IL-2-dependent
pDHSs play additional roles in supporting Th differentiation, and are
potentially also involved in the maintenance of priming by homeo-
static cytokines such as IL-7 and IL-15 in vivo.
To investigate the role of JAK/STAT signaling from IL-2 to the
primed DHSs, we treated cells with the JAK1/2 inhibitor Ruxolitinib
(INCB018424). TB cells were cultured for 30 h in IL-2 before addi-
tion of 1 lM Ruxolitinib for a further 16 h (Fig 1C). Ruxolitinib
treatment was sufficient to suppress 36% of the IL-2 pDHSs
compared to the DMSO control, thereby identifying a subset of IL-2-
dependent pDHSs that rely on STAT5 activity and not just AP-1
(Figs 2A, and EV1F and G).
The IL-2 dependence at pDHSs was exemplified by multiple
regions that we previously identified as primed in recently activated
T-blast cells (Bevington et al, 2016), including the Th2-specific LCR
(Fields et al, 2004) within the Rad50 gene (Fig 2E), which regulates
an archetypal Th2-specific cytokine gene cluster that includes Il4,
Il13, and Il5 (Bevington et al, 2017b), the Tnfsr9 locus, and the IL-2-
regulated Cish locus region (Li et al, 2017). For these loci, IL-2
pDHSs were present in CD4 TB IL-2 and CD4 TB DMSO cells, and
they were reduced upon IL-2 removal and by Ruxolitinib treatment.
Furthermore, an IL-2 and JAK1-dependent DHS was detected in the
Il17a locus, an archetypal Th17 gene (Fig EV1H). Although this
DHS did not qualify as one of the 1,000 high confidence IL-2 pDHSs,
due to the peak being below the threshold for detection in the
second TB IL-2 DNase-Seq replicate, it was clearly present in the
DMSO control used to define the Ruxolitinib sensitivity of this site,
and in Th17 cells (Fig EV1H). Notably, as exemplified by the CD3
gene cluster and Tbp loci, removal of IL-2 or treatment with Ruxoli-
tinib did not result in a global reduction in DNase I hypersensitivity
(Fig EV1I). In summary, our data show that IL-2 signaling is needed
to maintain epigenetic priming at recently reprogrammed committed
gene loci prior to terminal T cell differentiation.
IL-2-dependent DHSs bind IL-2-inducible factors
To define potential molecular mechanisms responsible for maintain-
ing epigenetic and transcriptional priming at pDHSs, we sought
evidence for specific priming factors binding to pDHSs so as to keep
them in an open conformation poised for rapid reactivation. Using
HOMER, we performed a de novo DNA motif search for enriched TF
consensus DNA-binding sequences within the IL-2 pDHSs, which
revealed that they were highly enriched in binding sites for the
JAK1/2-inducible factor STAT5 and the MAPK-inducible factor AP-1
(34 and 37% respectively) (Fig 3A).
We previously established that although the expression of most
AP-1 genes, including Fos, Fosb, Jun, and Junb, is highly TCR-
dependent in T cells, Jund mRNA is expressed at substantial levels
in the presence of just IL-2 (Bevington et al, 2016). In the present
study, we confirmed that the expression of Jund mRNA and JUND
protein is IL-2-dependent, as is the phosphorylation of STAT5
(Fig 3B and C). Furthermore, the locations of the STAT and AP-1
consensus motifs were highly concentrated within the most strictly
IL-2-dependent fraction of DHSs (Fig 3D). DNA motifs for the
constitutively expressed RUNX and ETS family TFs were also highly
enriched within the IL-2 pDHSs (Fig 3A), but these motifs were not
restricted to the IL-2-dependent DHSs (Fig 3D).
To confirm the identities of specific members of TF families
bound at consensus motifs in pDHSs, we performed chromatin
immunoprecipitation assays (ChIP-Seq) for the IL-2-inducible TFs
JUND and STAT5 in TB IL-2. Two replicate samples were used to
confirm that both transcription factors were enriched at the IL-2
pDHSs (Figs 3E and EV2A). We also performed a single ChIP-Seq
assay for JUND and STAT5 in TB IL-2nil just to confirm that their
binding was indeed lost in parallel with the loss of pDHSs in the
absence of IL-2 (Figs 3E and EV2B). Curiously, strong STAT5 bind-
ing was also seen at the shared IL-2-independent DHSs in the
absence of IL-2 (Fig 3E). Hence, it is likely that significant levels of
binding of presumably un-phosphorylated STAT5 still occur
throughout the genome in the absence of IL-2 (Fig 3E). Others have
also previously observed that STAT5 phosphorylation is not essen-
tial for it to associate with DNA (Park et al, 2016). Examples of
reduced STAT5 and JUND binding when IL-2 is absent are observed
at primed regions within TCR-inducible immune response genes
such as Il13, Gzmb, and Il24 (Fig 3F). As an additional control, we
also demonstrated that overall levels of STAT5, ETS1, and RUNX1
did not change in response to IL-2 (Fig EV2C). Taken together, these
data suggest that IL-2-regulated proteins are required to maintain a
subset of pDHSs in recently activated T cells.
Loss of IL-2 signaling correlates with suppression of inducible
DHSs at previously activated genes
To investigate whether IL-2 not only maintains primed DHSs but also
regulates inducible immune response genes, we activated TCR
signaling in TB IL-2 and TB IL-2nil with PMA and calcium ionophore
(PMA/I) for 2 h (TB+) and then performed DNase-Seq. We identified
6,805 iDHSs that were at least 2-fold inducible in T cells cultured
with IL-2 in each of two replicates (Figs 4A and EV3A), and in paral-
lel, 1,399 DHSs that were decreased by at least 2-fold in T cells stimu-
lated cells in the absence of IL-2 (Figs 4B and EV3B). By intersecting
these data sets, we defined 1,015 IL-2-dependent iDHSs (IL-2 iDHSs)
(Figs EV3C and 4A–C, Table EV1). Both the entire group of 6,805
iDHSs and the subset of 1,015 IL-2-dependent iDHSs had essentially
the same molecular signature, i.e., being highly enriched for motifs
for the inducible AP-1, NFAT, and EGR TF families (Figs 4D and
EV3D), which is consistent with their function as inducible transcrip-
tional enhancers (Bevington et al, 2016). Furthermore, the IL-2
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Figure 2. A subset of pDHSs in previously activated T cells are dependent on IL-2.
A DNase-Seq tag density plots showing all peaks detected in replicate 1 of TB IL-2 and TB IL-2nil (32,694) ordered by increasing fold change of tag count for TB IL-2
compared to TB IL-2nil. The sequence tag density is also shown in parallel at the same sites for the DNase-Seq analyses of CD4 naïve T cells (TN), TB IL-2 DMSO, and
TB IL-2 Ruxolitinib and ATAC samples from in vivo-derived Th2 (Shih et al, 2016), Th1, and Th17 cells. The location of the 1,000 IL-2 pDHSs is shown to the right.
B Average DNase-Seq tag density profile for the 1,000 IL-2 pDHSs in both replicates of TB IL-2 and TB IL-2nil samples, and for naïve T cells (TN).
C Number of IL-2 pDHSs which are detected in in vivo purified CD4 T cell subsets (Shih et al, 2016; Garg et al, 2019; Chen et al, 2020).
D Overlap between the subsets of IL-2 pDHSs which are present in in vivo-derived Th1, Th2, and Th17 cells.
E UCSC genome browser tracks with examples of IL-2 pDHSs within the locus control region (LCR) within the Rad50 gene which controls the Th2 cytokines Il13, Il4, and
Il5, plus IL-2 pDHSs within the Tnfrsf9 and Cish loci. IL-2 pDHSs are highlighted with blue boxes.
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Figure 3. IL-2 pDHSs bind IL-2 regulated factors.
A De novo identification of DNA consensus motifs enriched in the 1,000 IL-2 pDHSs determined by HOMER.
B Jund mRNA levels in TB IL-2 and TB IL-2nil. Standard deviation is shown from the mean of 3 samples. P-values were calculated from the RNA-Seq data using Limma
with Benjamini-Hochberg correction for multiple testing.
C Western blot analyses showing JUND and pSTAT5 protein levels in TB IL-2 and TB IL-2nil (left panel) with the signal calculated from 2 replicates relative to TB IL-2 in
the right panel.
D DNA motif density plots (right) showing the location of binding motifs for RUNX, ETS, STAT, and AP-1 transcription factors at the 32,694 DHSs detected in TB IL-2 and
TB IL-2nil, as depicted in Fig 2A, ordered according to fold enrichment of DNase-Seq tag counts in TB IL-2 compared to TB IL-2nil (left).
E DNA sequence tag density plots from ChIP-Seq assays of RUNX1, ETS1, STAT5, and JUND in TB IL-2, and STAT5 and JUND in TB IL-2nil ordered as in (D).
F UCSC genome browser tracks at the Il13/Il4/Il5 Th2 cytokine locus LCR (indicated by the gray box within the Rad50 gene), Gzmb and Il24 showing DNase-Seq and
ChIP-Seq for STAT5 and JUND in TB IL-2 and TB IL-2nil. Replicate JUND and STAT5 ChIP-Seq tracks are shown for TB IL-2.
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iDHSs were not inducible in TN cells which had not yet undergone
reprogramming or been exposed to IL-2 (Fig 4C). Taken together,
these data suggest that the cc cytokines as a family have the potential
to maintain a long-term transcriptional memory of the gene activa-
tion program that is initiated by TCR signaling and autocrine IL-2
expression when T cells become activated for the first time. This
program appears to be (i) established when naı̈ve T cells transform
into blast cells, (ii) supported by IL-2 during their expansion phase,
and IL-4 during Th2 differentiation, and (iii) is likely to be subse-
quently maintained by the homeostatic cytokines IL-7 and IL-15
when T cells return to the quiescent state as memory T cells. This
model of locus priming is further supported by the fact 10% of the
1,000 IL-2-dependent pDHSs had a IL-2-dependent iDHS within
25 kb (Fig 4E), suggesting a functional local cooperation between
the two distinct classes of regulatory elements. This close coopera-
tion is consistent with the model present in Fig 1A. Examples of this
are shown at the Csf2/Il3 and Il10 loci, where both primed and indu-
cible DHSs are present in T-blast cells whereas these loci are devoid
of priming in naı̈ve T cells where the inducible sites cannot be
formed (Fig 4F). At the Il10 locus, the same IL-2 pDHSs are known
to be to be strongly primed when T cells are rendered tolerant by
escalating dose peptide immunotherapy and converted to Tr1-like
regulatory T cells (Bevington et al, 2020).
Loss of IL-2-dependent pDHSs correlates with reduced
gene expression
To determine the extent by which IL-2 signaling is required to main-
tain efficient inducible responses in previously activated T cells, we
investigated (i) whether the removal of IL-2 had a direct impact on
steady-state gene expression, and (ii) whether the associated
decrease in pDHS and iDHS formation in the absence of IL-2 affected
the level of inducible gene expression. We performed RNA-Seq anal-
ysis in TB cells  IL-2 (TB IL-2 and TB IL-2nil) and  PMA/I (TB+ IL-
2 and TB+ IL-2nil) (Fig 5A and B). While 51% of the variance in
gene expression was accounted for by activation with PMA/I, regard-
less of whether the cells had been exposed to IL-2 (TB IL-2 compared
to TB+ IL-2, and TB IL-2nil compared to TB+ IL-2nil), 22% of the
variance was attributed to the presence of IL-2 (Fig 5A and B).
Furthermore, correlation clustering showed that the presence of IL-2
had the biggest impact on gene expression prior to stimulation (TB
IL-2 compared to TB IL-2nil; Fig 5B) with 612 genes being more than
3-fold upregulated in TB IL-2 compared to TB IL-2nil and 356 genes
that were at least 3-fold down-regulated when IL-2 was present (adj
P < 0.05) (Fig 5C, Table EV2). Many of the IL-2-dependent genes
were associated with the cell cycle, such as the histone genes and the
cell division cycle (cdc) genes (Table EV2), consistent with a role for
IL-2 in this process. Genes which became more active when IL-2 was
removed included genes involved in T cell homeostasis which are
normally associated with a cell signature more reminiscent of naı̈ve
T cells, such as Tcf7, Ccr7, and Cd62l (Sell).
To examine the impact of IL-2 pDHSs on IL-2-dependent gene
expression, we plotted the fold change in gene expression between
TB IL-2nil compared to TB IL-2 for the nearest gene to all the DHSs
plotted in the union of TB IL-2 and TB IL-2nil (Fig 5D). Genes associ-
ated with IL-2 pDHSs showed a general trend of being dependent
upon IL-2 (Fig 5D). These included immune regulatory genes such
as Tnfrsf9 and Cish (Fig 2E), Gzmb (Fig 3F), and Socs1 (Fig 5E). At
the Sell locus, RNA expression is higher in TB IL-2nil consistent with
the formation of DHSs which are also present in naı̈ve cells (Fig 5F),
a trend which is generally observed at the IL-2nil upregulated DHSs
(Fig 5D). Overall, these data indicate that primed DHSs which are
either created or erased in the presence of IL-2 do play a role in
controlling IL-2-dependent changes in steady-state gene expression
in previously activated T cells.
IL-2 signaling is required for rapid reactivation of some key
immune response genes
The above correlation clustering indicated that the presence of IL-2
also modulated the inducible gene repertoire of recently activated T
cells, but to a much lesser extent than seen for steady-state gene
expression (Fig 5B). To further investigate this subset, we identified
465 genes which were upregulated at least 3-fold in TB+ compared
to TB (Table EV2) and assessed whether recent prolonged exposure
to IL-2 was required for efficient and rapid reactivation of these
genes. However, removal of IL-2 in TB+ IL-2nil cells affected the
induction of just 14 genes by at least twofold (Table EV2). While the
number of genes was modest, it is striking that many key immune
response genes and genes harboring IL-2-dependent pDHSs and
iDHSs were included in this group, such as Il13, Ifng, Csf2, Il3, Il24,
and Il31. For some of these genes, the data were further validated
by quantitative PCR analysis (Fig 6A). We also demonstrated that
the same genes were less inducible when TB+ IL-2 cells were treated
with the JAK1/2 inhibitor Ruxolitinib which inhibits signaling from
IL-2 to STAT5 (Fig 6B). The dependence upon IL-2 signaling was
exemplified at the Il3/Csf2 and Il13 loci where withdrawal of IL-2
led to a decrease in inducible gene expression that was linked to a
decrease in both primed and inducible DHSs (Fig 6C).
The role of IL-2 in maintaining chromatin priming can be
replaced by IL-7
The above studies established that IL-2 maintains chromatin prim-
ing at IL-2 pDHSs in TB cells cultured in vitro (Fig 2A) and that this
form of priming exists in memory T cells formed in vivo (Fig 2C–E).
Although IL-2 is likely to contribute to the initial reprogramming of
naı̈ve T cells to effector T cells in vivo, the long-term maintenance
of IL-2 pDHSs most likely relies on alternative homeostatic cytoki-
nes such as IL-7 in lymph nodes, or IL-15 in tissues, which also acti-
vate cc family receptors (Hara et al, 2012; Raeber et al, 2018).
To investigate whether other cc receptors can fulfill the same role
as IL-2, we began by replacing IL-2 with IL-7 in the TB culture model
employed above (Fig 1C). Duplicate DNase-Seq analyses confirmed
that IL-7 had the ability to reproducibly maintain a similar subset of
pDHSs as compared to those maintained by IL-2 and that these
pDHSs were also lost upon IL-7 withdrawal (Fig 7A), as depicted by
the average sequence tag density at the 1,000 sites (Fig 7B). As
shown above for IL-2, the IL-7-dependent pDHSs included sites in
the Th2 LCR within Rad50, and sites at the Tnfrsf9 and Cish loci
(Fig 7C), while sites at the CD3 gene cluster and Tbp loci were unaf-
fected by IL-7 (Fig 7D). In support of the data in Fig 4C for IL-2, we
also demonstrated that a subset of iDHSs were less inducible in TB+
IL-7 cells after IL-7 withdrawal (Fig 7E) and that this affected the
expression of inducible genes in TB+ IL-7nil cells compared to TB+
IL-7 cells (Fig 7F).
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Figure 4. IL-2 signaling supports PMA/I-inducible DHS formation.
A, B DNase-Seq tag density plots showing all peaks detected in replicate 1 of TB IL-2 and TB+ IL-2 (A, 38,645) and in TB+ IL-2 and TB+ IL-2nil (B, 36,067), ordered by
increasing fold change in tag count as indicated. The position of the 1,015 IL-2-dependent inducible DHSs is shown alongside.
C Average DHS signal at the 1,015 IL-2-dependent inducible DHSs in TB IL-2, TB+ IL-2, TB+ IL-2nil, and naïve T cells stimulated with PMA/I (TN+).
D De novo identification of DNA consensus motifs enriched at the 1,015 IL-2 iDHSs as determined by HOMER.
E Bar graph showing the number of IL-2 iDHSs found within 25 kb of an IL2 pDHS.
F Examples of IL-2 iDHSs which are proximal to IL-2 pDHSs at the Csf2/Il2 and Il10 loci. IL-2 iDHSs are highlighted in red and IL-2 pDHSs in blue.
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The IL-7 receptor is required to maintain a subset of IL-2 pDHSs
in Ag-specific memory T cells
The detection of 39% of the IL-2 pDHSs in in vivo-generated 2W1S-
specific Th1 memory T cells (Fig 2C) 56 days post-infection
indicates that these sites are epigenetically stable when the TCR
signals are down-regulated. We therefore investigated whether the
stable in vivo maintenance of pDHSs was IL-7-dependent using
CD4creERT2 × Il7rf/f to inducibly delete IL-7Ra expression once Ag-
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Figure 5. Loss of IL-2 priming correlates with reduced gene expression of proximal genes.
A Principle component analysis (PCA) of TB IL-2, TB IL-2nil, TB+ IL-2, and TB+ IL-2nil from 3 replicates.
B Hierarchical clustering of RNA-Seq data from 3 replicates as described in (A).
C MA plot showing the genes differentially regulated between TB IL-2nil and TB IL-2. The number of genes with a fold change > 3 and adj P-value < 0.05 are
highlighted. P-values were calculated from the RNA-Seq data using Limma with Benjamini-Hochberg correction for multiple testing.
D log2 fold change in gene expression in TB IL-2nil compared to TB IL-2 for the nearest gene to the DHSs ranked according to the fold change in DNase-Seq tag count
for TB IL-2/TB IL-2nil. The DNase-Seq tag density plots are taken from Fig 2A for TB IL-2, TB IL-2nil, and TN.
E, F UCSC genome browser tracks showing DNase-seq and RNA-Seq at the Socs1 (E) and Sell loci (F).
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further crossed onto a ROSA26tdRFP background to facilitate detec-
tion of cre expression. CD4creERT2 × Il7rf/f mice and their Il7rf/f mice
littermate controls were infected with Lm-2WIS to generate Th1
cells as in Fig 1D. After approximately 3 weeks, administration of
tamoxifen was used to induce cre-mediated excision of exon 3 of the
Il7r gene (Fig 8A). Flow cytometric analyses 2 weeks later con-
firmed efficient deletion of IL-7Ra expression on the 2W1S-specific
CD4 memory T cells (Fig 8B). To determine the impact of loss of IL-
7Ra expression by memory CD4 T cells, 2W1S:I-Ab+,CD44+, RFP+,
IL-7Ra CD4 T cells were sorted from CD4creERT2 × Il7rf/f mice,
alongside 2W1S:I-Ab+, CD44+, IL-7Ra+ CD4 T cells from Il7rf/f
controls and harvested for ATAC-Seq. The number of IL-7ra-defi-
cient cells recovered from the CD4creERT2 × Il7rf/f mice was 40% of
the number of IL7ra+ cells harvested from the Il7rf/f controls
(Fig 8C), suggesting that loss of IL-7Ra leads to a 2.5-fold reduction
in Th1 memory T cell expansion and/or survival.
A substantial reduction in ATAC-Seq signal after disruption of
Il7r was apparent at the specific subset of 411 of the 1,000 IL-2
pDHSs which contain a STAT-binding motif (Figs 8D and EV4A).
This reduction, while relatively modest, is consistent across three
replicates and likely reflects the reality that signals through other
gamma chain receptors such as IL-2, IL-4, and IL-15 are still active.
Examples can be seen at the Gzmb, Il4ra, and the Pilrb loci (Fig 8E)
where the IL-2 pDHSs are reduced in samples where the IL-7 recep-
tor is inactivated. Furthermore, these sites bind STAT5 in TB IL-2
and this binding is reduced when the IL-2 is absent. Control regions
at the Tbp locus and the CD3 gene cluster are included to show that
a general loss of signal is not observed (Fig EV4B).
IL-2 pDHSs play a role in terminal T cell differentiation
The relatively modest effect of IL-2 withdrawal on inducible gene
expression in recently activated T cells (Fig 6) led us to look for
additional roles for IL-2 dependent priming later in T cell develop-
ment. The transformation of naı̈ve T cells to actively dividing Th0
blast cells represents just the first stage of T cells developing further
into various alternative types of mature differentiated effector T cells
equipped for combatting different types of infections (Fig 1B). The
different branches of terminal T cell differentiation involve addi-
tional alternative cytokine and TF-dependent epigenetic reprogram-
ming events subsequent to the TCR/CD28-dependent
reprogramming that occurs during blast cell transformation to Th0
T cells (Fig 1B). We demonstrated above that many of the IL-2-
dependent pDHSs are hypersensitive in primary Th cells (Figs 2A
and 2C–E) and that a Th2-specific cytokine gene locus harbors
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Figure 6. Loss of IL-2 priming correlates with reduced gene expression of some inducible genes.
A, B Relative mRNA expression levels in TB+ IL-2 and TB+ IL-2nil (A) and TB+ DMSO and TB+ Ruxolitinib (B). The expression level in the IL-2/DMSO TB+ sample is set to 1.
(n = 3, error bars represent standard deviation, P-values were calculated using a paired t-test with *P < 0.05, **P < 0.005, ***P < 0.0005.)
C UCSC genome browser tracks showing DNase-Seq and RNA-Seq at the IL-2 regulated genes Csf2/Il3 and at the LCR within the Rad50 gene (gray box) which
controls the Th2 cytokines Il13, Il4, and Il5. IL-2 pDHSs are highlighted in blue and IL-2 iDHSs in red.
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To further explore the interplay between IL-2 pDHSs, lineage-deter-
mining TFs, and specific STAT proteins, we analyzed publically
available data sets from terminally differentiated T cells. We inter-
sected STAT4 and T-BET ChIP-Seq peaks from Th1 cells (Wei et al,
2010; Gokmen et al, 2013), STAT6 and GATA3 peaks from Th2 cells
(Wei et al, 2010, 2011), and STAT3 and RORct from Th17 cells
(Durant et al, 2010; Ciofani et al, 2012) and overlapped these with
the 1,000 IL-2 pDHSs. Strikingly, we found that 62.5% of the IL-2
pDHSs go on to bind both an alternative cytokine-specific STAT
protein and a lineage-determining TF in Th1, Th2, or Th17 cells
(Fig 9A). As an additional control for these studies, we also used a
parallel method of inducing T cell blast transformation using CD3
and CD28 antibodies in place of ConA. This analysis confirmed that
the same set of DHSs (82–89%) were also primed by IL-2 in T-blast
cells generated by a more physiological method, which rules out the
possibility of inappropriate priming by ConA (Fig 9A). These obser-
vations are summarized by the model in Fig 9B which illustrates
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Figure 7. IL-2 pDHSs can be maintained in vitro by IL-7 in place of IL-2.
A DNase-Seq tag density plots showing all peaks detected in replicate 1 of TB IL-2 and TB IL-2nil (data taken from Fig 2A), duplicate DNase-seq samples for TB IL-7
and TB IL-7nil are shown in parallel for the same sites.
B Average DNase-Seq tag density profile for the 1,000 IL-2 pDHSs in both replicates of TB IL-7 and TB IL-7nil.
C, D UCSC genome browser tracks with DNase-Seq data for TB IL-7 and TB IL-7nil showing examples of IL-2 pDHSs within the locus control region (LCR) within the
Rad50 gene which controls the Th2 cytokines Il13, Il4, and Il5, plus IL-2 pDHSs within the Tnfrsf9 and Cish loci (C), and non-primed control regions from the CD3
gene cluster and the Tbp locus (D). IL-2 pDHSs are highlighted with blue boxes.
E Average DHS signal at the 1,015 IL-2 regulated inducible DHSs in TB+ IL-7 and TB+ IL-7nil.
F Relative mRNA expression levels in TB+ IL-7 and TB+ IL-7nil. The expression level in the TB+ IL-7 is set to 1. (n = 3, error bars represent standard deviation, P-values
were calculated using a paired t-test with *P < 0.05, **P < 0.005, ***P < 0.0005.)
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exposure to differentiation-inducing signals. This model is exempli-
fied by UCSC browser screenshots depicting key genes representa-
tive for the different T cell subsets: The Tbx21 and Il12rb2 loci in
Th1 cells, the Th2 cytokine locus (Il4 and Il13) in Th2 cells, and the
IL17a and Il12rb2 loci in Th17 cells (Fig 9C). In each case, the DHSs
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Figure 8. IL-2 pDHSs are reduced in antigen-specific memory T cells upon deletion the IL-7 receptor.
A Experimental overview of the tamoxifen-inducible disruption of Il7r following generation of 2W1S-specific Th1 memory T cells. CD4creERT2 × Il7rf/f or Il7rf/f (littermate
control) mice were injected i.v. with Lm-2W1S, tamoxifen administered for 4 consecutive days (19–21 dpi), and spleen cells harvested for ATAC-Seq 14–18 days later.
B Flow cytometric analysis of IL-7Ra expression by 2W1S-specific CD44hi CD4 T cells in the presence or absence of cre recombinase.
C Average number of 2W1S-specific cells recovered/mouse after sorting 3 replicate samples of Il7rf/f compared to CD4creERT2 × Il7rf/f. Errors bars indicate the standard
deviation.
D Average ATAC-Seq signal at the 411 IL-2 pDHSs which contain a STAT-binding motif.
E UCSC genome browser tracks at loci with IL-2 pDHSs showing replicate ATAC-Seq samples for CD4creERT2 × Il7rf/f memory T cells, Il7rf/f control memory T cells,
replicate DNase-Seq samples for TB IL-2 and TB IL-2nil and TB IL-2 and TB IL-2nil STAT5 ChIP-Seq samples. The gray boxes signify IL-2 pDHSs which diminish after
disruption of the Il7r gene.
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in the T-blast (Th0) cells prior to differentiation. This suggests a
bookmarking mechanism, whereby IL-2/IL-7-inducible STAT5 and/
or AP-1 maintain the pDHSs prior to differentiation. This renders TB
cells permissive to responding to alternative gene regulation
programs when the STAT proteins are exchanged or complemented
by lineage-determining factors binding to the same accessible
regions. Hence, priming by IL-2 or IL-7 responsive TFs is crucial for
keeping genes accessible and receptive to fate-determining factors
encountered later. Interestingly, although GATA3 and STAT6 are
not required for the initial opening up of the first two DHSs that
appear within the Th2 LCR in Th0 cells, two additional sites within
the LCR recruit GATA3 downstream, and STAT6 upstream of the
two central sites which bind GATA3 and STAT6 after differentiation
to Th2 cells (Fig 9C). Similar phenomena are observed at the Il17a
and Il12rb2 loci. This suggests a model, whereby Th lineage-specific
genes are activated in a stepwise process whereby the initial priming
is driven by IL-2 in Th0 cells and the line-specific program is consol-
idated by other lineage-defining cytokines and transcription factors
which can also activate additional regulatory elements.
Many IL-2 pDHSs are shared between Th lineages
It is significant that a large proportion of IL-2-dependent pDHSs are
shared between Th1, Th2, and Th17 cells. However, this also raises
questions as to the various roles of IL-2 because IL-2 was previously
thought to play opposing roles during the differentiation of Th1 and
Th17 cells. While IL-2 promotes the formation of Th1 cells, it inhi-
bits the differentiation of the Th17 lineage (Laurence et al, 2007;
Liao et al, 2011b; Yang et al, 2011; Fujimura et al, 2013) which are
also dependent on the AP-1 family member JUNB. Junb expression
increases during polarization toward the Th17 lineage and condi-
tional deletion of Junb impairs the expression of classical Th17
genes (Carr et al, 2017). While we observe PMA/I-inducible Junb
expression in undifferentiated T-blast cells (Fig 10A), it is unlikely
to play a role in maintaining the IL-2 pDHSs as, unlike JUND, it does
not bind to the pDHSs in the absence of stimulation with PMA/I
(Fig 10B; Bevington et al, 2016), and the inducible levels of Junb
mRNA are actually greater in the absence of IL-2 (Fig 10A). Consis-
tent with the IL-2 pDHSs being maintained in differentiated T cells,
published data show that 41% of the IL-2 pDHSs are bound by JUNB
in Th17 cells (Carr et al, 2017) and over half of these are bound by
JUND in TB IL-2 (Fig 10C). This suggests that the balance of AP-1
factors at the same site could be key to determining Th cell fate when
the cells are exposed to different cytokines during polarization.
Furthermore, Th17 cell differentiation may be suppressed by IL-2 via
the maintenance of JUND binding at the pDHSs. Consistent with this,
using published data from Th17 cells where Junb is conditionally
deleted, we can show that JUND binding to the IL-2 pDHSs increases
after loss of JUNB (Carr et al, 2017; Fig 10D). This is exemplified at
the Il17a Th17 cytokine locus where JUND binds to a DHS which is
reduced when IL-2 is absent in T-blast cells (Th0) and JUNB binds to
the same site in Th17 cells (Fig 10E). Furthermore, when JUNB is
ablated, JUND binding increases and, as shown by Carr et al (2017),
Il17a expression is reduced (Fig 10E). This suggests that JUND could
play a role in repressing Il17a in this context. Indeed, JUND has been
implicated as a repressive factor previously (Meixner et al, 2004),
and in TB+ IL-2 cells from Jund
/ mice, the inducible genes Ccl1,
Csf2, and Il24 are boosted compared to TB+ cells from Jund
+/+ mice
(Fig 10F). However, although this data suggest that the IL-2-induced
repression of Th17 differentiation may be in part mediated by JUND
binding to the pDHSs, this is likely to be just one of many mecha-
nisms by which IL-2 suppresses Th17 differentiation. IL-2 is also
known to suppress pathways promoting Th17 differentiation by (i)
suppressing expression of IL6Ra (Liao et al, 2011b) and (ii) by induc-
ing STAT5 which displaces STAT3, leading to loss of activation of
Th17 target genes (Yang et al, 2011).
Conversely, the binding of JUNB to some of the IL-2 pDHSs
represses specific genes in Th17 cells (Carr et al, 2017). At the Irf8
locus, a known repressor of Th17 differentiation (Ouyang et al,
2011), the 21 kb IL-2 pDHS is bound by JUND in T-blast cells and
JUNB in Th17 cells (Fig 10G; Carr et al, 2017). Consistent with this,
the subsequent deletion of Junb increased JUND binding and Irf8
expression (Fig 10G; Carr et al, 2017). In conclusion, IL-2 pDHSs
may display different activity in different Th subsets. This is further
reflected by the level of p300 binding which is elevated in Th17 cells
and not Th1 cells at the Il17 locus (Fig 10E) and in Th1 cells only at
the Irf8 locus (Fig 10G; Ciofani et al, 2012; Vahedi et al, 2012).
Therefore, the maintenance of these sites, albeit in a repressed state,
may be key to the plasticity between the subsets.
Discussion
It is well established that cytokine signaling to STAT proteins
promotes the activation of lineage-determining TF genes, and in
activating lineage-specific gene expression programs in differenti-
ated T cells (Fig 1B; Liao et al, 2011a; Vahedi et al, 2012; Ross &
Cantrell, 2018; Leonard et al, 2019). However, it was not previously
appreciated just how extensive a role that IL-2 signaling to AP-1 and
STAT5 played in making recently activated T cells more receptive to
T cell differentiation driven by other STAT proteins such as STAT3,
STAT4, and STAT6. The role of STAT5 in differentiation was largely
attributed to key regulators such as the IL-4 and IL-12 receptors and
their downstream targets (Liao et al, 2008, 2011b).
Based on the above data, and previously published studies, we
propose that the development and maintenance of the effector T cell
repertoire relies on both (i) the initial autocrine IL-2 signaling
induced when TN cells first encounter antigen-presenting cells, and
(ii) signaling from other cc family cytokines such as IL-7 and IL-15
once recently activated T cells or memory T cells relocate into
lymph nodes or peripheral tissues. The evidence presented here
strongly supports a model whereby cc cytokine signaling establishes
and/or maintains an active accessible chromatin environment
permissive to (i) receiving signals from TFs driving lineage-specific
gene expression, and (ii) reactivation by TCR signaling when previ-
ously activated T cells re-encounter Ag (Fig 9B). For example, the
intensively studied Th2 LCR within the Rad50 locus comprises
seven distinct DHSs in Th2 cells where it controls activation of the
Th2-specific IL-4, IL-13, and IL-5 genes (Fields et al, 2004). This
locus is epigenetically reprogrammed and primed with active
histone modifications within 24–48 h of activation of TCR signaling
when TN cells transform into TB cells (Bevington et al, 2016,
2017b). However, just two of these DHSs are initially opened up as
epigenetically primed DHSs when Th0 cells are first activated (Bev-
ington et al, 2016, 2017b). Significantly, both of these pDHSs, plus
two flanking DHSs which are acquired in Th2 cells (Fields et al,
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2004), have the ability to bind GATA3 and STAT6 in Th2 cells. The
first two Rad50 pDHSs lie directly adjacent to an iDHS (Bevington
et al, 2016) with known enhancer function (Fields et al, 2004)
which suggests that they play a pioneering role in the activation of
this locus prior to Th2 differentiation and locus activation. Lineage-
determining factors such as T-BET, GATA3, and RORct may
Il4 Il13 Il17a
Il12rb2
A 625 out of 1000 IL-2 pDHSs bind a STAT and a 
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therefore not be true pioneer factors for the activation of whole loci,
but initially home in on sites rendered accessible by IL-2 signaling
and chromatin reprogramming at an earlier stage during blast cell
transformation. A similar notion was recently proposed in a study
of the human RORC locus whereby TCR signaling to NFAT initially
promotes chromatin accessibility in this locus prior to terminal dif-
ferentiation, thereby creating a permissive environment for factors
induced by polarizing cytokines (Yahia-Cherbal et al, 2019).
In support of this model, an increasingly important role for IL-2
during CD4 and CD8 memory T cell formation has now emerged,
both for the initial priming of genes during the first phase of T cell
activation (Dooms et al, 2004, 2007; Williams et al, 2006; Pepper
et al, 2011), and for maintaining immunity when effector T cells
revert to memory T cells (McKinstry et al, 2014). Indeed, memory
T cell recall was impaired in Listeria monocytogenes-infected mice in
CD4 T cells not expressing the IL-2 receptor on day 3 of the primary
response (Pepper et al, 2011). An independent study using LCMV-
infected mice showed that IL-2 was required during the first 6 days
of infection in order for CD8 memory T cells to mount an efficient
response to the secondary infection (Williams et al, 2006). More
recently, IL-2 has also been shown to be required for the formation
of tissue-resident memory T cells (TRM) in the lung (Hondowicz
et al, 2016). The need for IL-2 exposure early during T cell activa-
tion suggests an IL-2-dependent priming mechanism causing herita-
ble changes to the epigenome which are maintained through T cell
expansion, differentiation, contraction, and homeostasis. This idea
is consistent with several recent studies which suggest that memory
T cells are derived from effector T cells which have been previously
activated and have subsequently proliferated (Akondy et al, 2017;
Youngblood et al, 2017) rather than formed from a population of
naı̈ve T cells which have bypassed antigenic activation (Restifo &
Gattinoni, 2013). However, IL-2 alone cannot by itself account for
the long-term maintenance of AP-1/STAT-dependent immunological
memory. IL-2 is a T cell-derived growth factor that requires ongoing
TCR signaling for its expression. Hence, the role of IL-2 in locus
priming would need to be replaced by other factors such as the cc
cytokine IL-7, which is expressed by stromal cells in lymph nodes,
the cc cytokine IL-4 expressed by Th2 cells (Ben-Sasson et al, 1990),
and IL-15 which is important for tissue-resident memory T cells
(Mackay et al, 2015). Consistent with this model, we demonstrate
here that IL-7 (and by inference other cc cytokines such as IL-15
and IL-4 as well) can functionally substitute for IL-2 to maintain
epigenetic priming of pDHSs occupied by AP-1 and STAT5 in
recently activated TB cells.
Chromatin priming enables specific gene expression programs
We previously defined pDHSs as a discrete class of gene regulatory
element, distinct from classically defined transcriptional enhancers,
which function in T cells to maintain active chromatin domains in
an accessible chromatin conformation while having little impact on
steady-state levels of transcription (Bevington et al, 2016, 2017a).
Chromatin priming is a key mechanism contributing to the regula-
tion of developmental and lineage-specific gene expression in many
cell types and contexts, ensuring that genes are able to respond to
signals and that they are expressed at the right time and place
(Bonifer & Cockerill, 2017). During development, genes are typically
activated in a stepwise fashion, and chromatin priming often occurs
prior to the actual onset of transcription (Gualdi et al, 1996;
Kontaraki et al, 2000; Walter et al, 2008; Mercer et al, 2011; Wang
et al, 2015; Goode et al, 2016; Huang et al, 2016). For example,
during macrophage development, PU.1 binding provides the cue
and creates the accessibility for additional factors to bind to macro-
phage-specific or inducible genes (Ghisletti et al, 2010; Heinz et al,
2010; Glass & Natoli, 2016). Also in macrophages, many enhancers
remain in an inactive state until they are activated for the first time
by STAT and AP-1 proteins and then persist in a primed latent state
hypersensitive to reactivation (Ostuni et al, 2013).
We previously reported that NFAT is a major mediator of cyclos-
porin A-sensitive chromatin opening downstream of TCR signaling
at enhancers which require cooperation between both NFAT and
AP-1 (Cockerill et al, 1993; Johnson et al, 2004). More recently, a
dominant-negative derivative of FOS has been used to show that
AP-1 is also essential for chromatin opening downstream of TCR
signaling (Yukawa et al, 2019). This activity of AP-1 may now help
to explain how IL-2 signaling is also able to maintain chromatin
accessibility at primed genes once they have been rendered accessi-
ble by prior TCR signaling.
As a class of DNA elements in T cells, pDHSs were previously
thought to be formed by a hit-and-run mechanism whereby tran-
sient expression of AP-1 induced by TCR signaling was required to
cooperate with other factors to initially open up nucleosome-free
regions that could then be stably maintained by constitutively
expressed factors such as RUNX1 and ETS1. Here, we now show
that IL-2-dependent pDHSs represent a subset of this class of regula-
tory element which are created by TCR and IL-2 signaling, but
require subsequent reinforcement from cc cytokine-inducible AP-1
and STAT5 for their maintenance. In this model, IL-2 and/or IL-7
function as true homeostatic factors whereby they are insufficient to
induce immune response genes, and may even suppress some
programs until the right factor is encountered. Evidence suggests
that the IL-2-inducible AP-1 family member JUND suppresses rather
than activates immune responses (Meixner et al, 2004), in keeping
with the low levels of gene expression seen at many primed genes
in the absence of TCR-inducible FOS and JUN expression (Bevington
et al, 2016, 2017a). Furthermore, the forced expression of JUND
suppresses activation of the Th2 gene expression program (Meixner
et al, 2004). Differentiation along the Th17 pathway may also
◀ Figure 9. IL-2 pDHSs are present in Th1, Th2, and Th17 cells.A Venn diagram showing the overlaps between subsets of the 1,000 IL-2 pDHSs which are also identified as ChIP-Seq peaks for STAT6 (Wei et al, 2010) and GATA3 (Wei
et al, 2011) in Th2 cells (161), STAT4 (Wei et al, 2010), and T-BET (Gokmen et al, 2013) in Th1 cells (510), and STAT3 (Durant et al, 2010) and RORct (Ciofani et al,
2012) in Th17 cells (333). The table below indicates the proportion of these peaks also seen in T blasts generated using CD3/CD28 antibodies instead of ConA.
B Model demonstrating priming of Th0 cells by IL-2-inducible AP-1 and STAT5 prior to binding of lineage-determining factors to the same regions.
C UCSC genome browser tracks showing ChIP-Seq and DNase-Seq at the LCR within the Rad50 gene which controls the Il4/Il13/Il5 Th2 cytokine locus, and also Il17a,
Il12rb2, and Tbx21. The gray boxes indicate IL-2 pDHSs which bind STAT5 in Th0 cells and other STAT proteins in other T cell lineages.
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Figure 10. JUNB and JUND bind to IL-2 pDHSs in multiple T cell lineages.
A mRNA expression levels of JUN family transcription factors. Normalized TPM is shown for TB IL-2, TB IL-2nil, TB+ IL-2, and TB+ IL-2nil. Standard deviation is shown for 3
replicates.
B Average JUNB ChIP-Seq signal at the 1,000 IL-2 pDHSs in TB IL-2 and TB+ IL-2 (Bevington et al, 2016).
C Overlap of the 411 JUNB bound IL-2 pDHSs in Th17 cells (Carr et al, 2017) with the 376 JUND bound IL-2 pDHSs in T-blast (Th0) cells.
D Average JUND ChIP-Seq signal at the 1,000 IL-2 pDHSs in Junb+/+CD4Cre (Junb WT) and Junbf/fCD4Cre (Junb KO) Th17 cells.
E Genome browser tracks showing open chromatin (DNase-Seq or ATAC-Seq) and ChIP-Seq in Th0, Th1, and Th17 cells at the Il17a locus (Ciofani et al, 2012; Vahedi
et al, 2012; Carr et al, 2017). The gray box indicates a DHS which binds JUND.
F Fold change in gene expression in TB+ IL-2 cells for Jund
/ compared to Jund+/+ mice. Data from 2 replicates are shown.
G Genome browser tracks showing open chromatin (DNase-Seq or ATAC-Seq) and ChIP-Seq in Th0, Th1, and Th17 cells at the Irf8 locus. The gray box indicates an IL-2
pDHS which binds JUND.
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initially be enabled by IL-2-dependent priming of Th17-specific
genes, such as IL-17a, but then stalled because expression of IL6Ra
is suppressed by IL-2, and IL-17a expression is dependent on the IL-
6-dependent induction of STAT3 (Liao et al, 2011a,b; Yang et al,
2011). Therefore, Th17 cells may require a relative loss of IL-2
signals to fully differentiate.
Taken together, our data suggest that the basic framework under-
lying lineage-specific effector T cell gene expression programs is laid
down during the earliest stages on T cell activation and is kick-
started by TCR/IL-2-dependent signaling processes. This set of
signals is sufficient to enable Th0 cells to progress down distinct
alternative developmental pathways, depending which environment
they encounter. Once established, the priming of immune response
genes can be maintained in the long term by homeostatic cytokines
in effector T cells once these cells return to quiescence as memory T
cells. This type of progressive activation of gene loci, via coopera-
tion between functionally distinct classes of regulatory element, is





C42 transgenic mice were described previously (Mirabella et al,
2010). C42 mice contain a 130-kb DNA fragment of the human IL3/
CSF2 locus. The mice were back-crossed with C57 Black 6 mice
(C57BL/6J) for over 10 generations. To track Th17 cells in vivo,
Il17acre mice (Hirota et al, 2011), crossed to ROSA26tdRFP mice
(Luche et al, 2007), were used to fate-map IL-17a expression. To
inducibly delete Il7r in vivo, CD4creERT2 mice (Aghajani et al, 2012)
(obtained from JAX) were crossed with Il7rf/f mice (McCaughtry
et al, 2012) and then additionally crossed with ROSA26tdRFP mice
(Luche et al, 2007) to aid detection of cre activity. Jund/ mice
were described previously (Thepot et al, 2000) and maintained as
Jund+/ mice for breeding. Animals were used in accordance with
Home Office guidelines at the University of Birmingham. Mice were
housed at 21°C  2°C, 55% humidity ( 10%) with 12-h light
dark/cycle in 7-7 IVC caging with environmental enrichment of
plastic houses plus paper bedding.
T-blast cell culture, purification, and stimulation
Actively dividing T-blast cells (TB) were generated from freshly
isolated CD4 T cells purified from the spleens of C42, Jund+/+, or
Jund/ mice using MACS CD4 (L3T4) microbeads (Miltenyi). Cells
were cultured at 1 × 106 cells/ml in IMDM with 2 lg/ml Concana-
valin A for 40 h before the Concanavalin A was removed, and the
cells were maintained at 5 × 105 cells/ml in IMDM supplemented
with 50 U/ml recombinant murine IL-2 or IL-7 (PeproTech). To
allow for sufficient expansion, the cells were cultured for 30 h in
the presence of cytokine and then were either maintained with IL-2
or IL-7 alone, maintained in IL-2 with the addition of 1 lM Ruxoli-
tinib (STEMCELL Technologies) or were washed twice and resus-
pended in IMDM alone. Cells were cultured for a further 16 h, and
where required, dead cells were removed using the MACs dead cell
removal kit (Miltenyi #130-090-101) and analyzed for apoptotic cells
using FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen
#556547). Cells were either harvested immediately or stimulated for
2 h with 20 ng/ml phorbol myristate acetate and 2 lM calcium
ionophore A23187 (PMA/I) at 1 × 106 cells/ml in IMDM before
processing for experiments. For control purposes in Fig 9A, a paral-
lel method of generating T cell blasts was employed whereby freshly
isolated spleen CD4 T cells were cultured at 1 × 106 cells/ml in
IMDM with CD3 and CD28 antibodies for 40 h before maintenance
at 5 × 105 cells/ml in IMDM supplemented with 50 U/ml recombi-
nant murine IL-2 for 48 h.
Antigen-specific Th1 memory T cell generation and purification
C42 mice were infected with 107 actA-deficient L. monocytogenes
expressing OVA-2W1S (Lm-2W1S, kind gift from Dr. M. Jenkins)
through intravenous injection in the tail vein. Glycerol stocks of Lm-
2W1S, aliquoted into 1 ml cryovials, were centrifuged and washed
with sterile PBS before resuspending in adequate volume of sterile
PBS to obtain 107 bacteria per 200 ll.
To recover 2W1S-specific CD4 T cells, spleens from infected mice
were recovered 56 dpi, crushed through a nylon mesh, and treated
with Gey’s solution red blood lysis buffer. The 2W1S-specific
memory T cell pool was enriched by magnetic enrichment, as
described by Jenkins (Moon et al, 2009). The resulting cells were
stained with CD3-PE, CD4-PE-Cy7, CD44-FITC, B220-e450, CD11c-
e450, CD11b-e450, and 2W1S:Ab-APC. CD44hi 2W1S-specific CD4 T
cells were sort purified using a BD FACSAria Fusion cell sorter (BD)
to greater than 95% purity.
Antigen-specific memory T cell generation and purification of
Il7r+/+ and Il7r/ Th1 cells
CD4creERT2 × Il7rf/f × ROSA26tdRFP or Il7rf/f × ROSA26tdRFP (litter-
mate control) mice were infected as described above. 19–21 days
later, 200 ll 20 mg/ml tamoxifen was administered by oral gavage
for four consecutive days. 2W1S-specific CD4 T cells were recovered
from infected mice 14–18 days following the first treatment with
tamoxifen and processed as above. The resulting cells were stained
with CD3-AF700, CD4-PerCP-Cy5.5, CD8-BV510, B220-APC-Cy7,
CD11c-APC-Cy7, CD11b-APC-Cy7, CD44-BV786, IL-7Ra-BV421, and
2W1S:Ab-APC. The Il7rf/f × ROSA26tdRFP samples were sort purified
as CD44hi IL7Ra+ 2W1S-specific CD4 T cells, and the
CD4creERT2 × Il7rf/f × ROSA26tdRFP samples were purified as CD44hi
tdRFP+ IL-7Ra- 2W1S-specific CD4 T cells. Cells were sorted using a
BD FACSAria Fusion cell sorter to greater than 95% purity.
Generation of Th17 cells in vivo
To generate and label Th17 cells in vivo, Il17aCre × ROSA26tdRFP+
mice (kind gift from Dr. G Frankel) were orally infected with
~ 2 × 109 Citrobacter rodentium strain ICC169 in 200 ll PBS by oral
gavage 7 days before harvesting Th17 cells. Following fat removal,
colons were cut longitudinally into 0.5-cm sections and washed with
Hank’s Balanced Salt Solution (HBSS, Gibco) with 2% fetal bovine
serum. Tissue was incubated twice with HBSS 2 mM EDTA at 37°C
for 15 min and then digested in complete RPMI with 0.85 mg/ml
Collagenase V (Sigma), 1.25 mg/ml Collagenase D (Roche), 1 mg/
ml Dispase (Gibco), and 30 lg/ml DNAse I (Roche) at 37°C until
the connective tissue was fully digested (approximately 45 min).
Cells were passed through 100- and 70-lm strainers and stained
with LIVE/DEADTM Fixable Near-IR stain (Invitrogen) for 20 min on
ª 2020 The Authors The EMBO Journal e105220 | 2020 17 of 23
Sarah L Bevington et al The EMBO Journal
ice prior to antibody staining. Antibody staining was carried out on
ice for 1 h. Colon-derived cells were stained with antibodies raised
against the mouse antigens: CD45.2 (clone 104), B220 (clone RA3-
6B2), CD11b (clone M1/70), CD11c (clone N418), CD3 (clone
17A2), CD4 (clone RM4-5), CD8a (clone 58-6.7), and CD44 (clone
IM7). Live Th17 cells were purified as tdRFP+ CD4 T cells (fate
mapping IL-17a expression) using a BD FACSAria Fusion cell sorter
(BD) to greater than 95% purity.
DNase I hypersensitive site analysis
DNase I digestions were performed as previously described (Bert
et al, 2007). Briefly, permeabilized cells were digested at 5 × 106
cells/ml for 30 at 22°C in DNase I buffer (60 mM KCl, 15 mM NaCl,
5 mM MgCl2, 100 mM Tris–HCl pH 7.4, 1 mM EGTA pH 7.4, 0.3 M
sucrose, 0.2% NP40, 1 mM CaCl2, and DNase I). Reactions were
terminated by SDS (final concentration 0.5%) and treated with
0.5 mg/ml Proteinase K at 37°C overnight followed by 0.2 mg/ml
RNase A for 1 h. DNA was purified by phenol/chloroform extrac-
tion. A range of DNase I concentrations were used, and the optimal
digestion for DNase-Seq library preparation was determined as
described previously (Bevington et al, 2016).
Western blot analysis of proteins
Nuclear extracts were prepared using the Nuclear Complex Co-IP Kit
according to the manufacturer’s instructions (Active Motif #54001).
Protein extracts were separated by electrophoresis on 4-20% Mini-
PROTEAN TGXTM gels (Bio-Rad #4561096) in TGS (25 mM Tris,
190 mM glycine, 0.1% SDS) before transfer to nitrocellulose
membranes using a Trans-Blot TurboTM Transfer system (Bio-Rad).
Membranes were blocked with 5% (w/v) milk powder in TBS-
Tween (TBST) (20 mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween) at
room temperature for 1 h before incubation overnight at 4°C with
1:1,000 dilution of primary antibodies in 5% (w/v) milk powder in
TBST. Primary antibodies: JUND (Thermo Scientific #720035), p-
STAT5 (Y694) (Cell signaling #9351S) STAT5 (Santa Cruz #sc-
835X), RUNX1 (Abcam #ab23980), B2M (Abcam #ab75853), and
ETS1 (Santa Cruz #sc-350X). Membranes were washed with TBST
and incubated with 1:10,000 dilution of HRP linked anti-rabbit IgG
secondary antibody (Santa Cruz #sc-2054) for 1 h at room tempera-
ture. Membranes were visualized using the SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific #34577).
Chromatin immunoprecipitation
Chromatin Immunoprecipitation (IP) was carried out as described
previously using a double-cross-linking method (Bevington et al,
2016). Cells were resuspended at 3.3 × 106 cells/ml and cross-linked
for 45 min with 0.83 mg/ml Di(N-succinimidyl) glutarate (DSG—
Sigma). Cells were washed four times with PBS before resuspending
at 2 × 106 cells/ml and re-cross-linking for 10 min with 1%
formaldehyde (Pierce) in PBS. Reactions were quenched with
0.125 M glycine, washed twice with PBS, and incubated with Buffer
A (10 mM HEPES pH 8.0, 10 mM EDTA, 0.5 mM EGTA, 0.25%
Triton X-100) at 4°C for 10 min followed by Buffer B (10 mM HEPES
pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.01% Triton X-
100, 0.25% SDS) at 4°C for 10 min. Chromatin was sheared
(107 cells/ml) in IP Buffer I (25 mM Tris 1 M, pH 8.0, 150 mM NaCl,
2 mM EDTA, pH 8.0, 1% Triton X-100, and 0.25% SDS) using a
PicorupterTM (Diagenode) to fragments of ~ 500 bp. The supernatant
was collected and diluted 3-fold in IP Buffer II (25 mM Tris, pH 8.0,
150 mM NaCl, 2 mM EDTA, pH 8.0, 1% Triton X-100, 7.5% glyc-
erol). Chromatin from 2 × 106 cells was incubated with 2 lg JUND
(Santa Cruz #sc-74X) or STAT5 (Santa Cruz #sc-835X) coupled to
15 ll protein G Dynabeads (Dynal) for 2 h at 4°C. Beads were
washed with Buffer 1 (20 mM Tris–HCl, pH 8.0, 150 mM NaCl,
2 mM EDTA, pH 8.0, 1% Triton X-100, 0.1% SDS), twice with Buffer
2 (20 mM Tris–HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, pH 8.0, 1%
Triton X100, 0.1% SDS), LiCl buffer (10 mM Tris–HCl, pH 8.0,
250 mM LiCl, 1 mM EDTA, pH 8.0, 0.5% NP-40, 0.5% Na-deoxycho-
late) and twice with TE/NaCl buffer (10 mM Tris–HCl pH 8.0,
50 mM NaCl, 1 mM EDTA). Samples were eluted in 100 ll elution
buffer (100 mM NaHCO3, 1% SDS), and crosslinks were reversed
overnight at 65°C with proteinase K. DNA was purified using Agen-
court AMPure (Beckman Coulter) according to the manufacturer’s
instructions. Samples were analyzed and validated by qPCR.
Gene expression analyses
Total RNA was extracted from 1 × 106 cells using TRIzolTM (Invitro-
gen) according to the manufacturer’s instructions. Contaminating
DNA was removed using Turbo DNA-freeTM kit (Ambion). For RNA-
Seq, samples were further purified using the RNeasy MinElute
Cleanup Kit (Qiagen). First-strand cDNA synthesis was carried out
using Superscript II Reverse Transcriptase and Oligo dT (Invitrogen)
according to the manufacturer’s instructions. Expression levels were
measured by qPCR using Applied Biosystems SYBR Green master
mix. Statistics were generated from at least three samples using a














Assay for transposase accessible chromatin using sequencing
(ATAC-Seq)
The omni ATAC-Seq protocol was modified from Corces et al
(2017). Briefly, 2W1S-specific T cells were purified by flow cytome-
try from CD4creERT2 × Il7rf/f × ROSA26tdRFP mice (3,000–11,000
IL-7Ra-deficient cells) or from Il7rf/f × ROSA26tdRFP mice (8,000–
20,000 IL-7Ra+ cells). IL-17a fate-mapped Th17 cells were purified
by flow cytometry from Il17aCre × ROSA26tdRFP+ mice (50,000
tdRFP+ cells). Cells were resuspended in 50 ll ATAC transposition
reaction mix containing 25 ll 2× Tagment DNA Buffer (Illumina),
2.5 ll Tn5 transposase (Illumina), 16.5 ll PBS, 0.5 ll 10% Tween-
20, and 0.5 ll 1% Digitonin (Promega #G9441) and incubated for
20 min at 37°C. For the 2W1S-specific Th1 memory cells, 40,000
cells were resuspended in 50 ll ATAC transposition reaction mix
containing 25 ll 2× Tagment DNA Buffer (Illumina), 2.5 ll Tn5
transposase (Illumina), and 0.5 ll 1% Digitonin and incubated for
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30 min at 37°C. DNA was purified using the MinElute Reaction
Clean up kit (Qiagen #28204) before PCR amplification using
Nextera custom primers. Optimal amplification was achieved by a
qPCR side reaction as described (Corces et al, 2017). Amplified
DNA was subsequently purified using Ampure Beads (Beckman
Coulter) prior to validation. Libraries were sequenced on NextSeq
500/550 High Output kit v2 75 cycles (Illumina, FC 404-2005) at the
Genomics Birmingham sequencing facility.
Library preparation
DNA libraries from DNase I digestions and chromatin immunopre-
cipitation assays were prepared using the Kapa Hyper-Prep kit
according to the manufacturer’s guidelines. Libraries were indexed
and then amplified by PCR. For DNase-Seq, libraries were ampli-
fied for 12 PCR cycles, and for ChIP-Seq, libraries were amplified
for 16 cycles. DNA fragments from amplified libraries were agarose
gel electrophoresis purified to ensure the correct fragment lengths
were sequenced (Qiagen Gel purification Kit). Fragments of 200–
300 bp were selected for DNase-Seq libraries and 200–400 bp for
ChIP libraries. Libraries were validated by qPCR and quantified
using the Kapa quantification kit before pooling and sequencing on
NextSeq 500/550 High Output kit v2 75 cycles (Illumina, FC 404-
2005).
RNA libraries were prepared from 50 to 100 ng RNA using the
NEB Next UltraTM II Directional RNA library Prep kit for Illumina
(NEB, #E7760S) according to the manufacturer’s instructions. rRNA
was depleted using the NEBNext rRNA Depletion kit (NEB,
#E6310S). Libraries were quantified using the Kapa quantification
kit before pooling and sequencing on NextSeq 500/550 High
Output kit v2 150 cycles (Illumina, FC 404-2002).
Data analysis
Alignment, coverage, and peak detection of DNase-Seq, ATAC-Seq,
and ChIP-Seq data sets
Raw DNA sequencing reads were aligned to the NCBI and the
Mouse Genome Sequencing Consortium version mm9 Build 37 from
July 2007 using bowtie2 (Galaxy version 2.3.2.2) (Langmead & Salz-
berg, 2012) with the preset –very-sensitive-local. Duplicated reads
were removed from ChIP-Seq data using the Picard tool MarkDupli-
cates (Galaxy Version 2.7.1.1). Coverage files were generated using
MACs version 1.4.2 using –g mm –keep-dup auto –w -S as parame-
ters (Zhang et al, 2008).
Normalization of DNase-Seq data sets
To ensure that the most accurate coordinates were calculated for
each peak summit and to determine a complete set of summits for
all samples, the BAM files from the DNase-Seq experiments TB IL-2,
TB IL-2nil, TB+ IL-2, TB+ IL-2nil TB IL-7, and TB+ IL-7 were merged
using BamTools (Galaxy version 0.0.2). MACS2 callpeak (Galaxy
version 2.1.1) was then used to identify 91,313 summits across all
samples. The DNA sequence tags  200 bp from the peak summit
were counted for each individual sample using the annotatePeaks
function of the HOMER package (Heinz et al, 2010). The samples
were normalized to one another using a correction factor based on
the median of the top 25,000 peaks. Correction factors were then
used to normalize genome browser scales, average profiles, and
contrast levels in tag density profiles.
Normalization of ATAC-Seq data sets
A high confidence set of peaks was determined for the for the 3
CD4creERT2 × Il7rf/f × ROSA26tdRFP samples and the 3 Il7rf/f × ROSA26tdRFP
samples by intersecting the peaks determined by MACs (summit files
 200 bp) using the BEDTools v2.26.0 intersect function (Quinlan & Hall,
2010). The samples were normalized to one another using a correction
factor based on the median of the high confidence peaks. Reads were
counted  200 bp from the peak summit using the annotate peak func-
tion of the HOMER package (Heinz et al, 2010). Correction factors were
used to normalize genome browser scales and average profiles.
Normalization of ChIP data sets
ChIP samples were normalized according to the number of mapped
reads. These values were then used to normalize average profiles
and contrast levels in heatmaps.
Unions of DNase-Seq samples
DNase-Seq DNA sequence tags were counted in each sample at the
91,313 merged summits  200 bp. The significant peaks were then
identified using a cut-off to exclude background and insignificant
peaks. Two samples were compared by merging the peaks using the
sort and merge function of the bedtools package. This gave a union of
peaks with common and specific sites for each sample. The normal-
ized number of DNA sequence tags  200 bp from the summits of the
union was then compared between the two samples to give a fold
change difference. The data were visualized as sequence tag density
plots showing the aligned reads for two different samples at both
common and unique regions ordered according to the fold change dif-
ference in tag density of one sample compared to the other.
DNA sequence tag density profiles
DNA sequence tag density profiles were generated using the anno-
tatePeaks function of the HOMER package using -hist 10 -ghist -size
2000 as parameters. Images were generated using Java Treeview
(http://jtreeview.sourceforge.net/).
Average DNA sequence tag density plots
Average DNase-Seq, ATAC-Seq, and ChIP-Seq DNA sequence tag
density profiles were generated  1 kb around the DHS summit
using the annotatePeaks function of the HOMER package with -hist
10 -size 2000 as parameters.
Intersection of peak groups
Where duplicate samples were available, high confidence peak sets
were defined by overlapping the peak summits determined by MACs
( 200 bp) using BEDTools v2.26.0 intersect function (Quinlan &
Hall, 2010) before intersecting with other peak groups.
Motif discovery
De novo DNA motif analysis was performed using the findMotifs-
Genome.pl function of the HOMER package (Heinz et al, 2010).
Motifs were identified  100 bp from the peak summit. STAT5-
binding motifs were located within the IL-2 pDHSs using the Anno-
tatePeaks.pl function of the HOMER package.
Distance analyses
The distance between the IL-2 pDHSs and IL-2 iDHSs was calculated
using the BEDTools closestBed function (Galaxy Version 2.26.0.0).
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Public data sets
DNase-Seq data sets CD4 TM, CD4 TN, CD4 TN+ (Bevington et al,
2016), GEO accession number GSE67451. Th2 ATAC-Seq (Shih et al,
2016), GEO accession number GSE77695, Tfh ATAC-Seq (Chen
et al, 2020) GEO accession number GSE120532, Treg ATAC-Seq
(Garg et al, 2019), GEO accession number GSE121764. CD4 TB
RUNX1 and ETS1 ChIP-Seq data sets (Bevington et al, 2016), GEO
accession number GSE67443. Th2 GATA3 ChIP-Seq (Wei et al,
2011), GEO accession number GSE20898. Th2 STAT6 ChIP-Seq
(Wei et al, 2010), GEO accession number GSE22105. Th1 T-BET
ChIP-Seq (Gokmen et al, 2013), GEO accession number GSE40623.
Th1 STAT4 ChIP-Seq (Wei et al, 2010), GEO accession number
GSE22105. Th17 STAT3 ChIP-Seq (Durant et al, 2010), GEO acces-
sion number GSE21669. Th17 RORct ChIP-Seq and Th17 p300 ChIP-
Seq (Ciofani et al, 2012), GEO accession number GSE40918. JUNB
ChIP-Seq and JUND ChIP-Seq in Junb+/+CD4Cre and Junbfl/flCD4Cre
Th17 cells (Carr et al, 2017), GEO accession number GSE98414. WT
Th1 p300 ChIP-Seq (Vahedi et al, 2012), GEO accession number
GSE40463. Data were downloaded and processed as described
above.
RNA-Seq data analyses
Raw paired-end cDNA library sequence reads were processed prior
to alignment with Trimmomatic v0.32 (Bolger et al, 2014) in order
to remove any low-quality sequences and adapters. The processed
DNA sequence reads were then aligned to the mouse genome (ver-
sion mm9) using Hisat2 v2.1.0 (Kim et al, 2015) with default param-
eters. Gene expression levels were measured as Transcripts Per
Million (TPM) calculated with StringTie v1.3.3 (Pertea et al, 2015)
using RefSeq gene models as the reference transcriptome. Only
genes that could be detected with a TPM value greater than 1 in at
least one of the samples were retained for further analysis. TPM
values were normalized using upper-quartile normalization in R
v3.5.1 and further log2-transformed as log2(TPM + 1). Differential
gene expression analysis was carried using the limma package
v3.38.3 (Ritchie et al, 2015) in R. A gene was considered to be
significantly differentially expressed if it had a greater than 3-fold
change between experimental conditions, and a Benjamini-Hoch-
berg adjusted P-value < 0.05.
Principal components analysis (PCA) was carried out with the
log2-transformed gene expression values using the prcomp() func-
tion in R. Hierarchical clustering was carried out by first calculating
the Pearson correlation of the log2-transformed TPM values for each
pair of samples. These values were then clustered using complete-
linkage clustering of the Euclidean distances in R.
Data availability
All DNA sequence data generated for this study are deposited in the
GEO depository under GEO accession GSE147294 (http://www.ncb
i.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147294).
Expanded View for this article is available online.
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